Abstract: Obtaining well-ordered crystals remains a significant challenge in protein X-ray crystallography. Carrier-driven crystallization can facilitate crystal formation and structure solution of difficult target proteins. We obtained crystals of the small and highly flexible SPX domain from the yeast vacuolar transporter chaperone 4 (Vtc4) when fused to a C-terminal, non-cleavable macro tag derived from human histone macroH2A1.1. Initial crystals diffracted to 3.3 Å resolution. Reductive protein methylation of the fusion protein yielded a new crystal form diffracting to 2.1 Å . The structures were solved by molecular replacement, using isolated macro domain structures as search models. Our findings suggest that macro domain tags can be employed in recombinant protein expression in E. coli, and in carrier-driven crystallization.
Introduction
Carrier-driven crystallization, 1, 2 or chaperoneassisted crystallization, 3 describes the crystallization of a target protein by fusing it to a well-behaving protein tag, which may contribute to the formation of the crystal lattice. A small selection of wellcharacterized proteins has thus far been used as crystallization tags: Short fragments of fibrinogen and a-actin have been crystallized by fusing them to E. coli glutathione-S-transferase (GST) 4 or the catalytic domain of myosin II, 5 respectively. The b 2 adrenergic G protein-coupled receptor crystallized after inserting T4 lysozyme into a flexible loop region. 6 Several structures obtained by carrierdriven crystallization contain E. coli maltose binding protein (MBP) as a fusion tag 3 : the ectodomain of the human T cell leukemia virus type 1 gp21, 7 the yeast mating regulator MATa1 homeodomain, 8 segments of the amyloid-forming a-synuclein 9 and the fungal Kar3 kinesin motor domain. 10 Corsini et al.
demonstrated the importance of using small rigid linkers between the target protein and the fusion tag, when crystallizing the U2AF homology motif of splicing factor Pfu60 fused to E. coli thioredoxin A.
11
Given that there are high resolution structures available for most of the fusion proteins used thus Abbreviations: GST, glutathione-S-transferase; MBP, maltose binding protein; SEC, size-exclusion chromatography; TTM, triphosphate tunnel metalloenzyme; VTC, vacuolar transporter chaperone Statement of Significance: A novel fusion tag for recombinant protein expression and carrier driven crystallization is presented.
far, the fusion tag, besides assisting in the formation of diffracting crystals, can facilitate structure solution by molecular replacement. In addition, an increased stability of the fusion protein is frequently observed. 12, 13 We have recently reported that SPX domains of previously unknown biochemical function are sensors for inositol pyrophosphate signaling molecules, controlling phosphate (P i ) homeostasis in fungi, plants and animals. 14 The name SPX originates from the yeast SYG1 and Pho81 and the mammalian XPR1 proteins, all of which contain SPX domains (https:// www.ebi.ac.uk/interpro/entry/IPR004331). Comparing different eukaryotic organisms, we located this small, a-helical domain at the N-termini of proteins involved in P i transport 15, 16 and P i signaling, 17, 18 and as a single-domain protein in plants. 14, 19, 20 Previously, we mapped three sets of domains in the vacuolar transporter chaperone (VTC) complex, a multi-subunit protein assembly embedded in the vacuolar membrane in yeast cells. 21 
Results

SPX domains can be crystallized as macro domain fusion proteins
The VTC SPX domains contain highly conserved Ntermini and are connected to the catalytic TTM domain by a short linker 22 ( Fig. 1 The macro domain can be utilized to solve the phase problem
The non-methylated SPX ScVtc4 -macro fusion protein . We thus used all available macroH2A1.1 structures as search models in molecular replacement searches as implemented in the program PHASER. 29 The best solution comprises two macro domains derived from PDB entry 1YD9 25 in the asymmetric unit, which are related by a pseudo two-fold axis [ Fig. 3 (B,C)]. We refined this crystallographic dimer, which accounts for 50% of protein atoms in the asymmetric unit in the program autoBUSTER (see Methods) and used the resulting phase information as starting phases for density modification (solvent content is 0.65). The resulting density modified map at 3.3 Å revealed the presence of long segments of electron density, which could be modeled as two long ahelices forming the core of the SPX domain [ Fig Table I ].
14 Monoclinic crystals of the reductively methylated SPX ScVtc4 -macro fusion protein diffracted to 2.1 Å (PDB-ID 5IIT, 14 Table I ). The structure was solved using the macro domain PDB entry 1ZR3 26 and the two SPX core helices from the low resolution Figure 1 . The VTC complex harbors N-terminal SPX domains. Structure based sequence alignment of VTC subunits ScVtc2 (S. cerevisiae Vtc2; UniProt Acc. P43585), ScVtc3 (S. cerevisiae Vtc3; Q02725) and ScVtc4 (S. cerevisiae Vtc4; P47075) and including a secondary structure assignment calculated with the program DSSP 48 and based on PDB entry 5IIG. 14 Invariant and conserved residues are highlighted in dark-and light-purple, respectively. SPX ScVtc2 shows 62% and 32% sequence identity with SPX ScVtc3 and SPX
ScVtc4
, respectively. The two long core helices of the SPX domain are colored in light blue, surrounding helices are colored from yellow to red. The C-terminal catalytic TTM domain (a-helices in green, b-strands in blue) is connected to the SPX domain via a variable linker (in yellow). were assayed for crystallization, all of which contained a C-terminal 6xHis tag and either no fusion protein, a macro tag (macro domain of the human histone macroH2A1.1 26, 27 ), trxA (E. coli thioredoxinA 11 ) or the catalytic TTM domain 22, 23 of ScVtc4. (B)
Overview of the constructed macro domain expression plasmid providing a macro tag (human macroH2A1.1 residues 181-366) connected to the N-terminal SPX domain via a Ala-Gly-Ser linker and followed by a non-cleavable 6xHis tag. Target proteins can be inserted using the restriction enzymes XbaI/BamHI. (C) SDS-PAGE analysis of purified SPX ScVtc4 26xHis and SPX ScVtc4 -macro-6xHis fusion proteins expressed in E. coli. Fig. 4(A) ]. Remarkably, we found the Nterminal a-helical hairpin motif initially located in our 3.3 Å map, to be disordered in the 2.1 Å structure [ Fig. 4(B,C) ]. Importantly, the Ala-Gly-Ser linker is well-defined by electron density in the 2.1 Å structure [ Fig. 4(C) ]. We used this high-resolution SPX ScVtc4 -macro model to confirm the topology of the SPX domain and the directionality of a-helices in our low resolution maps. The refined models revealed that SPX domains fold into three-helix bundles with two central 80 Å long core helices and two shorter C-terminal helices, connected by short loops. The N-terminus appears flexible but can fold into an a-helical hairpin motif, which provides a binding site for inositol polyphosphate signaling molecules 14 [ Fig. 4(B,C) ].
Crystal packing involves SPX and macro domain protein-protein interactions
We next analyzed the arrangement of the SPX ScVtc4 and macroH2A1.1 domains in our two crystal forms (solvent content is 0.65 and 0.55 for the nonmethylated and methylated forms, respectively): Crystal lattice formation in our low-resolution structure of non-methylated SPX ScVtc4 -macro is achieved 
Discussion
Our experiments suggest that the macro domains are suitable tags for recombinant protein expression and carrier-driven crystallization. Based on our previous work on the histone variant macroH2A1.1, 26, 27 we employed this human macro domain as fusion tag as it (1) stably expresses to high levels in E. coli, (2) can be easily purified, (3) is very stable in minimal buffers, (4) crystallizes in many different lattice combinations [25] [26] [27] (PDB-IDs 1YD9, 1ZR3, 1ZR5, 2FXK, 3IID, 3IIF), and (5) provides solvent accessible N-and C-termini for the design of both N-and C-terminal (this study) protein fusions. It is of note that macro domains bind ADP-ribose with nano-to micromolar affinity. 26, 31 Thus, ADP-ribose could be used as an additive in carrier-driven crystallization.
In our previous co-crystallization experiments with the isolated macroH2A1.1 macro domain, ADPribose induced the formation of new crystal forms (compared to the existing 'apo' structures 25, 26 ), as ligand-binding induces a structural re-orientation of the C-terminal helix. 26, 27 Notably, the macro ADPribose binding pocket can accommodate a MES buffer molecule (e.g., PDB-ID 1ZR3 26 ), and we could only obtain crystals for the SPX ScVtc4 -macro fusion when using MES-based protein storage buffers. In addition to ADP-ribose, macro domains can also bind ADP, albeit with lower affinity. 26, 31 It might thus be possible to soak or co-crystallize macro fusion proteins with halogenated nucleotide variants, in order to introduce heavy atoms at defined positions in macro fusion protein crystal lattices for experimental phasing. Our work has focused on the use of the macroH2A1.1 macro domain, but many alternative macro domain structures have been reported from human (PDB-IDs 2X47, 32 Given that all these different macro domains produced well-diffracting crystals (n 5 61 were refined at a resolution between 1.5 and 2.5 Å ), one interesting approach to carrierdriven crystallization would be to screen target proteins in fusion with different macro domains and in the pre-or absence of ADP-ribose. In addition, it may be worthwhile to test linkers of different length and composition between the protein of interest and the macro fusion tag. Linker length is an important factor in carrierdriven crystallization as it determines the molecular dynamics between the target protein and the fusion tag. While too short linkers may cause expression and folding problems, long linkers may hinder crystal formation. 11 In the present study a short, AlaGly-Ser linker was used, which allowed for highlevel expression of the SPX ScVtc4 -macro fusion protein and which has well-defined electron density in our 2. . Based on our findings, we suggest that macro domains could be interesting fusion tags for recombinant protein expression and for the carrierdriven crystallization of 'difficult' target proteins.
Materials and Methods
Cloning and purification of proteins
The S. cerevisiae SPX ScVtc4 (amino acids 1-178) was cloned into plasmid pMH-HC using BspHI and XhoI restrictions sites. The plasmid provided a C-terminal non-cleavable 6xHis tag. For carrier-driven crystallization, a new plasmid was constructed which provides a C-terminal macro tag (amino-acids 181-366 of human histone macroH2A1.1) followed by 6xHis tag [pMH-macroHC, Fig. 2(B) ]. SPX ScVtc4 and the macro domain are connected by an Ala-Gly-Ser linker. Target proteins can be cloned utilizing the XbaI/ BamHI restriction sites. For recombinant protein expression, plasmids were transformed into E. coli BL21 (DE3) RIL cells and selected on LB-Agar plates containing kanamycin and chloramphenicol. 3 l terrific broth medium containing 30 mg/mL kanamycin and 34 mg/mL chloramphenicol were inoculated and cells grown to OD 600nm 5 0.6 at 378C. Then, the temperature was reduced to 168C and protein expression was induced by adding 300 lM Isopropyl-b-D-thiogalactopyranoside. After 16 hours, cells were harvested by centrifugation for 20 min at 4,000g at 48C. The pellet was washed with PBS buffer, resuspended in a small volume of lysis buffer (50 mM Tris/HCl pH 7.8, 500 mM NaCl, 2 mM b-mercaptoethanol [b-ME]) and snap-frozen in liquid nitrogen.
For protein purification, pellets from 3 l of bacterial culture were thawed and lysis buffer, supplemented with 0.1% (v/v) IGEPAL, 1 mM MgCl 2 , 500 units TurboNuclease (BioVision) and 2 tablets Protease Inhibitor Cocktail (Roche), was added to a final volume of 300 mL. Cells were lysed using an EmulsiFlex-C3 (Avestin) and the cell debris was removed by centrifugation for 1 hour at 7,000g at 48C. Proteins were purified by Ni 21 affinity chromatography using a 5 mL HisTrap HP column (GE Healthcare). After dialysing proteins against sizeexclusion chromatography (SEC) buffer (20 mM Mes pH 6.5, 300 mM NaCl, 0.5 mM TCEP) overnight at 48C, monomeric SPX ScVtc4 or SPX
ScVtc4
-macro peak fractions were isolated on a Superdex 75 HR 26/60 column (GE healthcare). Reductive methylation of SPX ScVtc4 -macro was carried out as described previously. 28 Methylated protein sample was re-purified by an additional SEC step. Purified proteins were concentrated and immediately used for crystallization.
Crystallization and data collection 14 Data processing and scaling was done with XDS (version: May, 2016). 45 Crystallographic structure solution and refinement
The structure of the non-methylated SPX ScVtc4 -macro domain was solved using the molecular replacement method as implemented in the program PHASER, 29 and using the isolated macro domain of human histone macroH2A1.1 (PDB-ID 1YD9 25 ) as search model. The solution comprised a dimer in the asymmetric unit, which was refined in autoBUSTER (Global Phasing Limited, version 2.10.3). The resulting phases were used as starting phases for density modification as implemented in PHENIX.RE-SOLVE. 46 The structure was completed in alternating cycles of manual model building in COOT 25 and restrained TLS refinement in autoBUSTER (Global Phasing Limited), using external reference restraints based on the high-resolution structures of the macroH2A1.1 macro (PDB-ID 1ZR3 26 ) and SPX ScVtc4 domains (PDB-ID 5IIG 14 ), respectively.
The side-chains of most amino acids in the SPX domain could not be modeled with certainty and were thus truncated to Ala. The quality of the refined structure was validated using the program MolProbity 47 (Table I) and structural presentations were prepared in PyMOL (Molecular Graphics System, Version 1.7 Schr€ odinger, LLC).
